|Featured Presenter: Lawrence Blonde, MD, FACP, FACE
1. Develop strategies to increase patient acceptance of
injectable therapies and explore treatment pathways
physicians can employ to overcome clinical inertia
associated with type 2 diabetes mellitus (T2DM)
2. Examine the latest clinical trial evidence for available and
emerging GLP-1 receptor agonists (GLP-1 RAs) with respect
to differences among agents, potential role in combination
therapy, and individualizing T2DM therapy to optimize
patient adherence and outcomes.
3. Compare and contrast available and emerging insulins
and develop strategies for timely initiation, selection,
intensification, and self-management of insulin therapy for
T2DM based on patient specific factors.
Sponsored by: Lilly and Novo Nordisk
This Live activity, Injectable Strategies for the Primary
Care Physician: Overcoming Barriers to Optimize Type 2 Diabetes
Management, from 03/07/2014 - 10/15/2014, has been reviewed
and is acceptable for up to 1.00 Prescribed credit(s) by the
American Academy of Family Physicians.
There is no fee to attend this activity.